Edwards Lifesciences (EW) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased compared to the immediately preceding period. However, it declined relative to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased compared to the immediately preceding period. However, it declined relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
+7.4%
Change from the immediately preceding quarter.
Year-over-year
-4.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $1.3B | +0.7% |
| Dec 31, 2022 | $429.9M | -67.7% |
| Mar 31, 2023 | $1.2B | -8.9% |
| Jun 30, 2023 | $1.3B | -4.5% |
Revenue performance
The reported revenue direction shows a sequential improvement from the prior quarter, recovering from the previous period's level.
Quarterly comparison
Compared with the immediately preceding quarter, revenue rose. In contrast, versus the same quarter one year ago, revenue was lower.
What to watch
The year-over-year decline contrasts with the sequential gain, indicating a mixed trend that warrants monitoring.